Previous studies have shown that TSLP promotes the expression of PD-L1 mRNA in synovial fluid and peripheral blood of patients with RA and inhibits the secretion of antigen-presenting molecules (HLA II and CD1c), costimulating factors (CD40, CD80, and CD86), and T cell chemokines. Here, CD40 is linked to rheumatoid arthritis.